摘要
目的:腹泻是儿科常见疾病,其治疗方式多是肠道保护与菌群调节相结合,本文采用双歧三联活菌片联合蒙脱石散治疗腹泻患儿,观察其对血清免疫蛋白、血锌水平的影响。方法:选取2017年6月1日-2018年6月1日笔者所在医院儿科腹泻患儿198例,密封信封法分为对照组和联合组,每组99例,对照组在基础治疗上予以蒙脱石散治疗,联合组在基础治疗上予以双歧三联活菌片联合蒙脱石散治疗,观察两组临床常见体征指标和症状缓解时间,比较其治疗前后免疫功能、肠道主要菌群和血锌的变化。结果:联合组血常规恢复时间、粪常规恢复时间、体温恢复时间、腹痛和呕吐缓解时间均早于对照组,差异均有统计学意义(t=15.95、14.12、13.07、18.74、20.86,P<0.05);治疗后,两组患儿免疫球蛋白A、免疫球蛋白G、CD4+、CD4+/CD8+均升高,CD8+均降低,且联合组各指标均优于对照组,差异均有统计学意义(P<0.05);治疗后,两组乳杆菌属、肠球菌属数量均升高,酵母样真菌均降低,且联合组菌群均优于对照组,差异均有统计学意义(P<0.05);治疗后,两组血锌水平均提高,且联合组高于对照组,差异均有统计学意义(P<0.05)。结论:双歧三联活菌片联合蒙脱石散能够促进患儿体征指标和临床症状的恢复,显著改善腹泻患儿血清免疫蛋白水平,提升血锌,改善肠道菌群。
Objective: Diarrhea is a common disease in department of pediatrics, and its treatment regimen is mostly combination of intestinal protection and flora regulation. In this paper, Bifid Triple Viable Tablet combined with Montmorillonite Powder was used for children with diarrhea to observe the effects on serum immune protein and blood zinc levels. Method: A total of 198 children with diarrhea in department of pediatrics of our hospital from June 1, 2017 to June 1, 2018 were selected and divided into control group and combined group according to the sealed envelope method, with 99 cases in each group. The control group was given Montmorillonite Powder on the basis of basic treatment, and the combined group was given Bifid Triple Viable Tablet combined with Montmorillonite Powder on the basis of basic treatment. The relief times of clinical common signs and symptoms were observed in the two groups, and the immune function, intestinal major flora and blood zinc were compared before and after treatment. Result: The recovery time of blood routine, fecal routine recovery, body temperature, abdominal pain and vomiting in the combined group were significantly earlier than those in the control group, the differences were statistically significant (t=15.95, 14.12, 13.07, 18.74, 20.86, P<0.05). After treatment, the immunoglobulin A, immunoglobulin G, CD4+, CD4+/CD8+ increased and CD8+ decreased in the two groups, and the indexes in the combined group were better than those in the control group, the differences were statistically significant (P<0.05). After treatment, the number of Lactobacillus and Enterococcus increased and the number of Yeast-like fungi decreased in the two groups, and the flora of the combined group was better than that of the control group, the differences were statistically significant (P<0.05). After treatment, the level of serum zinc in the two groups was increased, and the level of serum zinc in the combined group was higher than that in the control group, and the differences were statistically significant (P<0.05). Conclusion: Bifid Triple Viable Tablet combined with Montmorillonite Powder can promote the recovery of physical signs and clinical symptoms of children, significantly improve serum immune protein level, enhance blood zinc and improve intestinal flora in children with diarrhea.
作者
刘胜强
LIU Shengqiang(Hong’an People’s Hospital, Hong’an 438400, China)
出处
《中外医学研究》
2019年第28期4-7,共4页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
双歧三联活菌片
蒙脱石散
腹泻患儿
血清免疫蛋白
血锌
Bifid Triple Viable Tablet
Montmorillonite Powder
Children with diarrhea
Serum immune protein
Blood zinc